Affiliation:
1. InHealth Intelligence Ltd Winsford UK
2. Thirona B.V. Nijmegen The Netherlands
Abstract
AbstractAimsA diabetic eye screening programme has huge value in reducing avoidable sight loss by identifying diabetic retinopathy at a stage when it can be treated. Artificial intelligence automated systems can be used for diabetic eye screening but are not employed in the national English Diabetic Eye Screening Programme. The aim was to report the performance of a commercially available deep‐learning artificial intelligence software in a large English population.Methods9817 anonymised image sets from 10,000 consecutive diabetic eye screening episodes were presented to an artificial intelligence software. The sensitivity and specificity of the artificial intelligence system for detecting diabetic retinopathy were determined using the diabetic eye screening programme manual grade according to national protocols as the reference standard.ResultsFor no diabetic retinopathy versus any diabetic retinopathy, the sensitivity of the artificial intelligence grading system was 69.7% and specificity 92.2%. The performance of the artificial intelligence system was superior for no or mild diabetic retinopathy versus significant or referrable diabetic retinopathy with a sensitivity of 95.4% and specificity of 92.0%. No cases were identified in which the artificial intelligence grade had missed significant diabetic retinopathy.ConclusionThe performance of a commercially available deep‐learning artificial intelligence system for identifying diabetic retinopathy in an English national Diabetic Eye Screening Programme is presented. Using the pre‐defined settings artificial intelligence performance was highest when identifying diabetic retinopathy which requires an action by the screening programme.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference18 articles.
1. Type 1 diabetes in adults: diagnosis and management NICE guideline (NG17) 2022. Accessed September 9 2022.https://www.nice.org.uk/guidance/ng17
2. Type 2 diabetes in adults: management NICE guideline (NG28) 2022. Accessed September 9 2022.https://www.nice.org.uk/guidance/ng28
3. Prospective evaluation of an artificial intelligence-enabled algorithm for
automated diabetic retinopathy screening of 30 000 patients
4. Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application
5. Impact of introducing automated grading into the Scottish national diabetic retinopathy screening programme;Philip S;Diabet Med,2017
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献